BridgeMD
Compares treatment options for Hemiplegia
Official title Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients
ClinicalTrials.gov ID: NCT05260125
What this study is testing
What is Ultrasound-guided Suprascapular Nerve Block?
Ultrasound-guided Suprascapular Nerve Block is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for hemiplegia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to compare the effectiveness of ultrasound-guided and non-guided suprascapular nerve block in the treatment of patients with hemiplegic shoulder pain, which is one of the most common post-stroke complications.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 75
You may be able to join if
- Having hemiplegic shoulder pain for 3 months
- Visual analogue scale score \> 3 during passive shoulder joint movement on the hemiplegic side
You likely can't join if
- Mini mental test score \<24
- Patients with uncontrolled diabetes, coagulopathy
- Botulinum toxin administration in the past six months,
- Any injection in the shoulder region in the last six months
- Having hypersensitivity to injection agents
The study team makes the final eligibility decision.
Where it's taking place
- Bolu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bolu, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.